Apellis Pharmaceuticals (APLS) P/E (2018 - 2026)
Apellis Pharmaceuticals (APLS) P/E from Jan 2, 2018 to May 14, 2026. The TTM Apellis Pharmaceuticals (APLS) P/E is 39.02. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Apellis Pharmaceuticals (APLS)
| Year | P/E | Change |
|---|---|---|
| 2026 | 39.02 | -73.31% |
| 2025 | 146.19 | -842.07% |
| 2024 | -19.70 | +72.83% |
| 2023 | -11.40 | +32.55% |
| 2022 | -8.60 | +59.14% |
| 2021 | -5.40 | -56.80% |
| 2020 | -12.51 | +95.34% |
| 2019 | -6.40 | +12.25% |
| 2018 | -5.70 | N/A |
Comparison Apellis Pharmaceuticals (APLS) P/E with competitors
Apellis Pharmaceuticals (APLS) P/E is 39.02.